HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum.

Abstract
The aim of the present study was to assess the pharmacokinetics and the efficacy of a shorter than usual 5-day quinine treatment given orally to children in Cameroon with malaria caused by Plasmodium falciparum. Quinine (8.3 mg of base per kg of body weight every 8 h) was administered as a 2% formiate salt syrup for 5 days to 30 children (age range, 0.55 to 6.7 years) with uncomplicated falciparum malaria (initial parasitemia, 1.4 x 10(3) to 1.8 x 10(5)/microl). Quinine concentrations in plasma samples (five to nine per patient) were measured by liquid chromatography on days 1 to 3. Parasitemia was counted on days 0, 1, 2, 3, 4, 7, and 14. Pharmacokinetic and pharmacodynamic data were analyzed by population approaches by using NONMEM and WinBugs, respectively. The kinetics of quinine were best described by a one-compartment model with time-varying protein binding. Clearance and the volume of distribution were positively correlated with body weight and increased over time. Parasitemia was undetectable from day 3 to 14 in all children. The time to a 4-log reduction of the initial level of parasitemia (Ter) was related to the average quinine concentration from 0 to 72 h (Cav) as Ter = Tmin [1 + (C50/Cav)s], where sigmoidicity (s) is equal to 2, Tmin is the time to eradication at infinite Cav, and C50 is the value of Cav for which Ter is twice Tmin. The C50 distribution was unimodal, and all C50 values were less than 8 mg/liter, while Cav ranged from 5.9 to 18.3 mg/liter. The median (10th to 90th percentile) Ter was 47 h (range, 39 to 76 h). The efficacy of a 5-day treatment course should be evaluated in a larger clinical trial.
AuthorsM Le Jouan, V Jullien, E Tetanye, A Tran, E Rey, J-M Tréluyer, M Tod, G Pons
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 49 Issue 9 Pg. 3658-62 (Sep 2005) ISSN: 0066-4804 [Print] United States
PMID16127036 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antimalarials
  • Quinine
Topics
  • Administration, Oral
  • Antimalarials (pharmacokinetics, therapeutic use)
  • Bayes Theorem
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Malaria, Falciparum (drug therapy, parasitology)
  • Male
  • Population
  • Prospective Studies
  • Quinine (pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: